This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks

1 hour ago 2

Matt DiLallo, The Motley Fool

Mon, March 30, 2026 astatine 5:50 AM CDT 5 min read

The Schwab U.S. Dividend Equity ETF (NYSEMKT: SCHD) has a precise elemental strategy. It tracks an scale that aims to clasp the apical 100 high-yielding dividend stocks. That scale reshuffles its holdings erstwhile a twelvemonth to guarantee it contains lone the champion of the best.

The money precocious completed its yearly reconstitution. One of the much notable changes was an summation successful its allocation to high-yielding dividend stocks successful the healthcare sector. Here's a person look astatine immoderate of the fund's caller changes.

Will AI make the world's archetypal trillionaire? Our squad conscionable released a study connected the 1 little-known company, called an "Indispensable Monopoly" providing the captious exertion Nvidia and Intel some need. Continue »

A stethoscope connected apical of $100 bills.

The Schwab U.S. Dividend Equity ETF tracks the Dow Jones U.S. Dividend 100 Index. That scale screens dividend stocks based connected respective dividend prime characteristics, including dividend yield, five-year dividend maturation rate, and fiscal strength. It reconstitutes its holdings erstwhile a twelvemonth to guarantee it holds the 100 apical high-yielding dividend stocks.

At this year's reconstitution, the scale deleted 22 existing holdings and added 25 caller stocks. The 2 biggest additions were UnitedHealth (NYSE: UNH) astatine a 4% allocation and Abbot Laboratories (NYSE: ABT) astatine 3.95%, which are present apical 10 holdings on with chap healthcare giants Merck and Amgen. Meanwhile, a notable chopped was AbbVie (NYSE: ABBV), which antecedently had a 3.31% allocation. The nett effect is that the money has accrued its vulnerability to the healthcare sector from 15.4% to 18.9% of its holdings (its second-highest weighting, down user staples stocks).

The changes made to the portfolio won't person immoderate near-term interaction connected the ETF's dividend. The post-reconstitution holdings person astir the aforesaid output arsenic earlier the reconstitution, astatine 3.4%. However, the caller holdings person a higher mean dividend maturation complaint (9.4% mean implicit the past 5 years compared to 8.6% pre-reconstitution). As a result, the money should make much income for investors successful the agelong run. That faster dividend maturation complaint could alteration the money to make higher full returns for investors.

The Schwab U.S. Dividend Equity ETF is trading AbbVie for Abbott Labs and UnitedHealth. Unlike immoderate of the fund's caller deletions, AbbVie is inactive a top-notch dividend stock. The institution hiked its dividend by different 5.5% precocious past year. It has raised its payout each twelvemonth since its 2013 spinoff from Abbott Labs. AbbVie has grown its dividend by 330% since its formation. The healthcare institution besides inactive has an charismatic dividend output of 3.3%, astir triple the S&P 500's level of 1.2%.

Read Entire Article